Annual Total Assets
$36.83 M
-$30.81 M-45.55%
December 31, 2023
Summary
- As of February 8, 2025, ENLV annual total assets is $36.83 million, with the most recent change of -$30.81 million (-45.55%) on December 31, 2023.
- During the last 3 years, ENLV annual total assets has fallen by -$3.53 million (-8.74%).
- ENLV annual total assets is now -61.29% below its all-time high of $95.15 million, reached on December 31, 2021.
Performance
ENLV Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Assets
$29.80 M
-$2.10 M-6.60%
September 30, 2024
Summary
- As of February 8, 2025, ENLV quarterly total assets is $29.80 million, with the most recent change of -$2.10 million (-6.60%) on September 30, 2024.
- Over the past year, ENLV quarterly total assets has dropped by -$17.14 million (-36.52%).
- ENLV quarterly total assets is now -69.65% below its all-time high of $98.17 million, reached on September 30, 2021.
Performance
ENLV Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Assets Formula
Total Assets = Current Assets + Non-Current Assets
ENLV Total Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -45.5% | -36.5% |
| 3 y3 years | -8.7% | -50.4% |
| 5 y5 years | +233.8% | -50.4% |
ENLV Total Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -61.3% | at low | -68.7% | at low |
| 5 y | 5-year | -61.3% | +109.7% | -69.7% | +69.7% |
| alltime | all time | -61.3% | >+9999.0% | -69.7% | +9637.6% |
Enlivex Therapeutics Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $29.80 M(-6.6%) |
| Jun 2024 | - | $31.90 M(+2.8%) |
| Mar 2024 | - | $31.05 M(-15.7%) |
| Dec 2023 | $36.83 M(-45.6%) | $36.83 M(-21.5%) |
| Sep 2023 | - | $46.94 M(-11.5%) |
| Jun 2023 | - | $53.03 M(-11.7%) |
| Mar 2023 | - | $60.02 M(-11.3%) |
| Dec 2022 | $67.64 M(-28.9%) | $67.64 M(-6.6%) |
| Sep 2022 | - | $72.41 M(-6.4%) |
| Jun 2022 | - | $77.34 M(-12.7%) |
| Mar 2022 | - | $88.62 M(-6.9%) |
| Dec 2021 | $95.15 M(+135.8%) | $95.15 M(-3.1%) |
| Sep 2021 | - | $98.17 M(+3.1%) |
| Jun 2021 | - | $95.19 M(-0.8%) |
| Mar 2021 | - | $95.96 M(+137.8%) |
| Dec 2020 | $40.36 M(+129.8%) | $40.36 M(+20.9%) |
| Sep 2020 | - | $33.37 M(-5.8%) |
| Jun 2020 | - | $35.44 M(-5.9%) |
| Mar 2020 | - | $37.65 M(+114.4%) |
| Dec 2019 | $17.56 M | $17.56 M(-8.6%) |
| Sep 2019 | - | $19.22 M(-7.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $20.83 M(+9.4%) |
| Mar 2019 | - | $19.05 M(+72.6%) |
| Dec 2018 | $11.03 M(+204.6%) | $11.03 M(+547.5%) |
| Jun 2018 | - | $1.70 M(-53.0%) |
| Dec 2017 | $3.62 M(-65.9%) | $3.62 M(-15.4%) |
| Sep 2017 | - | $4.28 M(-22.3%) |
| Jun 2017 | - | $5.51 M(-30.1%) |
| Mar 2017 | - | $7.89 M(-25.8%) |
| Dec 2016 | $10.63 M(-48.2%) | $10.63 M(-20.5%) |
| Sep 2016 | - | $13.37 M(-21.1%) |
| Jun 2016 | - | $16.95 M(-24.6%) |
| Mar 2016 | - | $22.48 M(+9.6%) |
| Dec 2015 | $20.52 M(-37.7%) | $20.52 M(-14.2%) |
| Sep 2015 | - | $23.92 M(-11.1%) |
| Jun 2015 | - | $26.90 M(-9.9%) |
| Mar 2015 | - | $29.85 M(-9.4%) |
| Dec 2014 | $32.95 M(>+9900.0%) | $32.95 M(-4.6%) |
| Sep 2014 | - | $34.54 M(+664.8%) |
| Jun 2014 | - | $4.52 M(+1375.8%) |
| Dec 2013 | $306.00 K(+96.2%) | $306.00 K |
| Dec 2012 | $156.00 K | - |
FAQ
- What is Enlivex Therapeutics annual total assets?
- What is the all time high annual total assets for Enlivex Therapeutics?
- What is Enlivex Therapeutics annual total assets year-on-year change?
- What is Enlivex Therapeutics quarterly total assets?
- What is the all time high quarterly total assets for Enlivex Therapeutics?
- What is Enlivex Therapeutics quarterly total assets year-on-year change?
What is Enlivex Therapeutics annual total assets?
The current annual total assets of ENLV is $36.83 M
What is the all time high annual total assets for Enlivex Therapeutics?
Enlivex Therapeutics all-time high annual total assets is $95.15 M
What is Enlivex Therapeutics annual total assets year-on-year change?
Over the past year, ENLV annual total assets has changed by -$30.81 M (-45.55%)
What is Enlivex Therapeutics quarterly total assets?
The current quarterly total assets of ENLV is $29.80 M
What is the all time high quarterly total assets for Enlivex Therapeutics?
Enlivex Therapeutics all-time high quarterly total assets is $98.17 M
What is Enlivex Therapeutics quarterly total assets year-on-year change?
Over the past year, ENLV quarterly total assets has changed by -$17.14 M (-36.52%)